The Impact of Preexisting Severe Mental Disorders on Cancer Mortality: A Systematic Review and Meta-Analysis.
메타분석
1/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
환자: a known SMD diagnosis prior to their cancer diagnosis
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
[CONCLUSION] This review and meta-analysis highlighted a concerning higher relative cancer-specific mortality risk for patients with preexisting SMD. These findings underscore the need for integrated healthcare approaches addressing both cancer treatment and mental health to improve outcomes for this vulnerable population.
[PURPOSE] People with severe mental disorders (SMD) face a significantly lower life expectancy compared to people without SMD.
- 95% CI 1.30-1.44
- 연구 설계 systematic review
APA
Riis N, Vestergaard M, et al. (2026). The Impact of Preexisting Severe Mental Disorders on Cancer Mortality: A Systematic Review and Meta-Analysis.. Acta psychiatrica Scandinavica, 153(3), 158-178. https://doi.org/10.1111/acps.70054
MLA
Riis N, et al.. "The Impact of Preexisting Severe Mental Disorders on Cancer Mortality: A Systematic Review and Meta-Analysis.." Acta psychiatrica Scandinavica, vol. 153, no. 3, 2026, pp. 158-178.
PMID
41290405 ↗
Abstract 한글 요약
[PURPOSE] People with severe mental disorders (SMD) face a significantly lower life expectancy compared to people without SMD. Studies have reported divergent results concerning cancer-specific mortality. Therefore this systematic review and meta-analysis aimed to assess the cancer-specific mortality for people with preexisting SMD.
[METHODS] A comprehensive literature search was conducted across PubMed, Embase, Psycinfo, and Scopus for studies published since January 2003. Inclusion criteria targeted adult cancer patients with a known SMD diagnosis prior to their cancer diagnosis. Two authors independently screened records based on predefined criteria, resolving discrepancies through discussion. Data extraction and quality assessment were conducted using the Newcastle-Ottawa Scale. A random effects model was employed to conduct the analysis, with heterogeneity across the studies quantified using the I statistic.
[RESULTS] The search yielded 4736 records, of which 25 studies met the eligibility criteria. Findings consistently indicated higher cancer-specific mortality among patients with preexisting SMD, with a 1.37 (95% CI: 1.30-1.44) higher relative risk of cancer-specific mortality for patients with preexisting SMD. The highest mortality rates were found among patients with schizophrenia and other psychosis with a relative cancer mortality risk at 1.47 (95% CI: 1.33-1.63).
[CONCLUSION] This review and meta-analysis highlighted a concerning higher relative cancer-specific mortality risk for patients with preexisting SMD. These findings underscore the need for integrated healthcare approaches addressing both cancer treatment and mental health to improve outcomes for this vulnerable population.
[METHODS] A comprehensive literature search was conducted across PubMed, Embase, Psycinfo, and Scopus for studies published since January 2003. Inclusion criteria targeted adult cancer patients with a known SMD diagnosis prior to their cancer diagnosis. Two authors independently screened records based on predefined criteria, resolving discrepancies through discussion. Data extraction and quality assessment were conducted using the Newcastle-Ottawa Scale. A random effects model was employed to conduct the analysis, with heterogeneity across the studies quantified using the I statistic.
[RESULTS] The search yielded 4736 records, of which 25 studies met the eligibility criteria. Findings consistently indicated higher cancer-specific mortality among patients with preexisting SMD, with a 1.37 (95% CI: 1.30-1.44) higher relative risk of cancer-specific mortality for patients with preexisting SMD. The highest mortality rates were found among patients with schizophrenia and other psychosis with a relative cancer mortality risk at 1.47 (95% CI: 1.33-1.63).
[CONCLUSION] This review and meta-analysis highlighted a concerning higher relative cancer-specific mortality risk for patients with preexisting SMD. These findings underscore the need for integrated healthcare approaches addressing both cancer treatment and mental health to improve outcomes for this vulnerable population.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.